Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

6 structures for Q96S44

Entry ID Method Resolution Chain Position Source
6WQX X-ray 253 A C/D 1-253 PDB
7SZA X-ray 190 A A/C 1-253 PDB
7SZB X-ray 202 A A/C 1-253 PDB
7SZC X-ray 171 A A/C 1-253 PDB
7SZD X-ray 205 A A/C 1-253 PDB
AF-Q96S44-F1 Predicted AlphaFoldDB

238 variants for Q96S44

Variant ID(s) Position Change Description Diseaes Association Provenance
RCV002489515
RCV001252762
rs774069989
6 A>missing Galloway-Mowat syndrome 4 Microcephaly [ClinVar] Yes ClinVar
dbSNP
rs773814837
CA409258817
RCV000513023
VAR_080371
42 G>D Galloway-Mowat syndrome 4 GAMOS4 [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
ExAC
TOPMed
dbSNP
gnomAD
CA315726711
RCV001003631
rs886913294
43 A>V Global developmental delay [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
rs1431526147
RCV000513210
60 K>missing Galloway-Mowat syndrome 4 [ClinVar] Yes ClinVar
dbSNP
RCV000513568
VAR_080372
CA409258575
rs1432218739
81 T>R Galloway-Mowat syndrome 4 GAMOS4; abolished interaction with TPRKB [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
dbSNP
gnomAD
CA9891808
RCV001334428
rs45570735
113 M>V Galloway-Mowat syndrome 4 [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV000900183
CA9891792
rs56008408
RCV002495446
VAR_041882
145 T>A Galloway-Mowat syndrome 4 [ClinVar] Yes ClinGen
ClinVar
UniProt
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
rs200921554
CA9891772
COSM478236
RCV001334430
182 I>V kidney Galloway-Mowat syndrome 4 [Cosmic, ClinVar] Yes ClinGen
cosmic curated
ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
rs2063182741
RCV001330234
200 L>V Galloway-Mowat syndrome 4 [ClinVar] Yes ClinVar
dbSNP
RCV001003630
CA9891746
RCV002549220
rs553547069
RCV002221597
243 R>C Global developmental delay Galloway-Mowat syndrome 4 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
VAR_080373
RCV000513223
CA409269086
rs776588426
243 R>L Galloway-Mowat syndrome 4 GAMOS4 [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
ExAC
TOPMed
dbSNP
gnomAD
rs757587369
CA9891877
2 A>E No ClinGen
ExAC
TOPMed
gnomAD
CA409259049
rs757587369
2 A>V No ClinGen
ExAC
TOPMed
gnomAD
rs777970200
CA409259044
3 A>G No ClinGen
ExAC
gnomAD
CA9891875
rs777970200
3 A>V No ClinGen
ExAC
gnomAD
CA409259042
rs1450656312
4 A>T No ClinGen
gnomAD
rs372539814
CA9891874
4 A>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1025683425
CA315726989
5 R>G No ClinGen
TOPMed
rs767139349
CA9891872
5 R>T No ClinGen
ExAC
gnomAD
rs540226060
CA315726945
6 A>D No ClinGen
1000Genomes
ExAC
CA409259031
rs540226060
6 A>G No ClinGen
1000Genomes
ExAC
rs751472539
CA9891870
6 A>P No ClinGen
ExAC
TOPMed
gnomAD
rs751472539
CA9891871
6 A>T No ClinGen
ExAC
TOPMed
gnomAD
CA9891869
rs540226060
6 A>V No ClinGen
1000Genomes
ExAC
TCGA novel 7 T>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA409259027
rs1170387437
7 T>S No ClinGen
gnomAD
rs762765592
CA409259024
8 T>A No ClinGen
ExAC
gnomAD
CA9891866
rs113419087
RCV000890416
8 T>M No ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs762765592
CA9891867
8 T>P No ClinGen
ExAC
gnomAD
rs1473663579
CA409259019
9 P>A No ClinGen
TOPMed
gnomAD
rs956883915
CA315726918
9 P>L No ClinGen
gnomAD
rs1473663579
CA409259018
9 P>S No ClinGen
TOPMed
gnomAD
rs760896863
CA9891864
10 A>S No ClinGen
ExAC
gnomAD
CA9891863
rs775626954
10 A>V No ClinGen
ExAC
gnomAD
CA9891861
rs745915184
11 D>E No ClinGen
ExAC
TOPMed
gnomAD
rs200981640
CA9891860
12 G>R No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs200981640
CA9891859
12 G>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1321785132
CA409258999
13 E>* No ClinGen
gnomAD
rs542718885
CA9891857
14 E>D No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs747833775
CA9891855
15 P>L No ClinGen
ExAC
TOPMed
gnomAD
rs747833775
CA315726803
15 P>R No ClinGen
ExAC
TOPMed
gnomAD
rs756489681
CA9891856
15 P>S No ClinGen
ExAC
gnomAD
CA409258977
rs1361919704
16 A>V No ClinGen
TOPMed
gnomAD
CA9891853
TCGA novel
rs754653569
17 P>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
ClinGen
ExAC
gnomAD
CA409258970
rs1165407069
18 E>Q No ClinGen
gnomAD
CA409258930
rs1254269349
24 A>T No ClinGen
gnomAD
TCGA novel 25 A>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA9891850
rs758415773
25 A>S No ClinGen
ExAC
gnomAD
VAR_014427 25 A>T No UniProt
CA9891847
rs761561027
26 R>W No ClinGen
ExAC
TOPMed
gnomAD
CA409258917
rs1267622626
27 E>K No ClinGen
TOPMed
rs775714809
CA9891846
28 R>L No ClinGen
ExAC
gnomAD
rs1419726636
CA409258905
29 S>G No ClinGen
TOPMed
rs1229432298
CA409258901
29 S>T No ClinGen
gnomAD
rs759647587
CA9891843
31 R>G No ClinGen
ExAC
TOPMed
gnomAD
rs774558255
CA9891842
31 R>L No ClinGen
ExAC
gnomAD
rs759647587
CA409258888
31 R>S No ClinGen
ExAC
TOPMed
gnomAD
rs1388733208
CA409258876
33 L>V No ClinGen
gnomAD
CA9891841
rs770901961
34 S>R No ClinGen
ExAC
TOPMed
gnomAD
CA409258862
rs1438589758
35 G>S No ClinGen
gnomAD
TCGA novel 38 L>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs80207840
CA315726716
CA409258838
39 V>L No ClinGen
gnomAD
CA315726714
rs943975048
40 K>* No ClinGen
Ensembl
CA315726712
rs112762349
41 Q>P No ClinGen
Ensembl
CA409258819
rs1369459077
42 G>S No ClinGen
TOPMed
rs773814837
CA9891839
42 G>V No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 44 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs927085371
CA409258799
45 A>E No ClinGen
TOPMed
gnomAD
rs927085371
CA315726705
45 A>G No ClinGen
TOPMed
gnomAD
rs755200975
CA315726709
45 A>T No ClinGen
Ensembl
rs927085371
CA409258800
45 A>V No ClinGen
TOPMed
gnomAD
rs531398951
CA315726703
46 R>G No ClinGen
gnomAD
CA409258798
rs531398951
46 R>S No ClinGen
gnomAD
rs1246661367
CA409258792
47 V>M No ClinGen
gnomAD
CA9891837
rs748570199
49 R>C No ClinGen
ExAC
TOPMed
gnomAD
rs1226256476
CA409258775
49 R>L No ClinGen
gnomAD
rs948101601
CA315726656
51 R>G No ClinGen
TOPMed
rs556703444
CA409258766
51 R>H No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs556703444
CA9891836
51 R>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1365331134
CA409258757
52 F>L No ClinGen
gnomAD
rs1302585317
CA409258754
53 Q>* No ClinGen
TOPMed
gnomAD
CA409258752
rs1266448119
53 Q>R No ClinGen
TOPMed
rs1427826630
CA409258748
54 G>R No ClinGen
gnomAD
CA409258740
rs1435534871
55 R>C No ClinGen
TOPMed
gnomAD
CA409258741
rs1435534871
RCV000762349
55 R>G No ClinGen
ClinVar
TOPMed
dbSNP
gnomAD
CA409258734
rs1237153226
56 A>G No ClinGen
TOPMed
CA9891835
rs754723667
56 A>P No ClinGen
ExAC
TOPMed
gnomAD
CA409258732
rs1237153226
56 A>V No ClinGen
TOPMed
rs1451337186
CA409258722
58 V>A No ClinGen
TOPMed
gnomAD
rs1451337186
CA409258721
58 V>G No ClinGen
TOPMed
gnomAD
RCV000882966
CA9891834
rs568244503
58 V>L No ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
CA409258719
rs1410980626
59 I>V No ClinGen
TOPMed
TCGA novel 60 K>E Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA409258702
rs1394936725
61 H>R No ClinGen
gnomAD
rs1248738356
CA409258695
62 R>C No ClinGen
gnomAD
rs750395029
CA9891831
62 R>H No ClinGen
ExAC
gnomAD
CA409258679
rs1485319662
64 P>L No ClinGen
gnomAD
CA409258682
rs1568972563
64 P>S No ClinGen
Ensembl
CA409258677
rs1568972559
65 K>E No ClinGen
Ensembl
rs748123388
CA409258674
65 K>M No ClinGen
ExAC
gnomAD
CA9891829
rs748123388
65 K>R No ClinGen
ExAC
gnomAD
CA409258668
rs1211529991
66 G>D No ClinGen
gnomAD
CA409258658
rs1351453096
67 Y>* No ClinGen
TOPMed
CA409258655
rs1309995008
68 R>Q No ClinGen
gnomAD
CA409258651
rs1229114772
69 H>D No ClinGen
gnomAD
CA409258639
rs1367053804
70 P>L No ClinGen
gnomAD
CA409258643
rs1463821756
70 P>S No ClinGen
TOPMed
CA409258634
rs1329597789
71 A>G No ClinGen
TOPMed
rs1295074440
CA409258614
74 A>V No ClinGen
gnomAD
rs1381460993
CA409258609
75 R>Q No ClinGen
gnomAD
CA409258600
rs1380089687
77 G>S No ClinGen
gnomAD
rs1304815614
CA409258587
79 R>Q No ClinGen
gnomAD
CA409258584
rs1374990300
80 R>G No ClinGen
TOPMed
gnomAD
rs1169763191
CA409258579
81 T>A No ClinGen
gnomAD
CA409258576
rs1432218739
81 T>K No ClinGen
gnomAD
CA409258574
rs1432218739
81 T>M No ClinGen
gnomAD
rs1192846036
CA409258563
83 Q>R No ClinGen
TOPMed
gnomAD
rs1424760435
CA409258553
84 E>D No ClinGen
gnomAD
CA409258547
rs1256411084
85 A>V No ClinGen
TOPMed
gnomAD
rs923967363
CA409258539
87 A>S No ClinGen
TOPMed
gnomAD
rs923967363
CA315726625
87 A>T No ClinGen
TOPMed
gnomAD
CA409258527
rs1484391156
89 L>F No ClinGen
gnomAD
CA9891826
rs763873209
93 R>C No ClinGen
ExAC
TOPMed
gnomAD
CA315726620
rs763873209
93 R>G No ClinGen
ExAC
TOPMed
gnomAD
CA315726610
rs979633803
93 R>L No ClinGen
Ensembl
CA409258485
rs1568972507
94 A>S No ClinGen
Ensembl
rs1216839008
CA409258470
95 G>R No ClinGen
gnomAD
CA409271216
rs1237109848
96 I>M No ClinGen
TOPMed
CA409271189
rs1182194866
97 S>Y No ClinGen
gnomAD
rs1248322419
CA409271135
99 P>A No ClinGen
gnomAD
CA409271123
rs1430396787
99 P>R No ClinGen
gnomAD
rs369690944
CA9891814
100 V>A No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1267038690
CA409271047
101 V>F No ClinGen
gnomAD
rs1231266512
CA409270990
104 V>L No ClinGen
gnomAD
CA9891813
rs148722672
106 Y>C No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs148722672
CA409270971
106 Y>F No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA9891811
rs148722672
106 Y>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs548440276
CA315759167
107 A>S No ClinGen
gnomAD
rs1263315495
CA409270959
108 S>P No ClinGen
TOPMed
CA9891810
rs771638240
109 N>S No ClinGen
ExAC
TOPMed
gnomAD
CA409270938
rs1387898865
110 C>* No ClinGen
TOPMed
gnomAD
CA9891809
rs745434503
110 C>Y No ClinGen
ExAC
TOPMed
gnomAD
CA409270932
rs1455562419
111 L>S No ClinGen
TOPMed
CA409270924
rs1292100340
112 Y>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA315759145
rs948899461
112 Y>H No ClinGen
TOPMed
gnomAD
CA9891806
rs753763955
113 M>I No ClinGen
ExAC
gnomAD
CA9891807
rs532864581
113 M>T No ClinGen
1000Genomes
ExAC
gnomAD
TCGA novel 115 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs777637012
CA9891805
115 E>G No ClinGen
ExAC
gnomAD
CA409270894
rs1406282542
116 I>F No ClinGen
TOPMed
gnomAD
rs1438982629
CA409270885
117 E>* No ClinGen
TOPMed
CA9891804
rs755798850
119 S>P No ClinGen
ExAC
gnomAD
rs964818155
CA315759118
120 V>M No ClinGen
TOPMed
rs751828263
CA9891803
122 V>I No ClinGen
ExAC
TOPMed
gnomAD
rs1211533115
CA409270843
123 R>* No ClinGen
TOPMed
gnomAD
rs34983477
VAR_041881
CA9891802
123 R>Q No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA409270835
rs1262847372
124 D>G No ClinGen
TOPMed
rs1480475523
CA409270822
126 I>V No ClinGen
gnomAD
rs763202340
CA9891801
127 Q>R No ClinGen
ExAC
TOPMed
gnomAD
rs11550540
CA9891800
VAR_030870
129 T>A No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA409270795
rs1600643709
130 M>T No ClinGen
Ensembl
CA9891799
rs528622355
130 M>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA9891798
rs61729174
RCV000958071
135 T>I No ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs777207968
CA9891797
136 P>A No ClinGen
ExAC
TOPMed
gnomAD
rs769092427
CA9891796
140 S>F No ClinGen
ExAC
gnomAD
COSM277768
CA409270650
rs1379290692
152 R>* Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
gnomAD
CA409270648
rs149404267
152 R>L No ClinGen
ESP
TOPMed
gnomAD
CA315759038
rs149404267
COSM3423695
152 R>Q large_intestine Variant assessed as Somatic; 4.62e-05 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ESP
NCI-TCGA
TOPMed
gnomAD
TCGA novel 153 M>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA409270633
rs1460119601
154 H>R No ClinGen
TOPMed
CA409270627
rs1323031277
155 D>G No ClinGen
TOPMed
gnomAD
CA409270630
rs749230227
155 D>H No ClinGen
ExAC
TOPMed
gnomAD
CA9891789
rs749230227
155 D>N No ClinGen
ExAC
TOPMed
gnomAD
CA315759024
rs985927085
158 L>F No ClinGen
TOPMed
CA9891788
rs777533820
160 H>R No ClinGen
ExAC
TOPMed
gnomAD
CA409270555
rs1445443270
163 L>P No ClinGen
TOPMed
gnomAD
CA409270523
rs1201041350
165 T>I No ClinGen
gnomAD
rs752473080
CA9891786
166 S>T No ClinGen
ExAC
gnomAD
CA9891785
rs781036338
168 M>L No ClinGen
ExAC
gnomAD
CA9891784
rs138867729
169 L>F No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA9891783
rs750611965
171 K>I No ClinGen
ExAC
gnomAD
CA9891782
rs761941095
172 P>A No ClinGen
ExAC
gnomAD
CA9891781
rs761941095
172 P>S No ClinGen
ExAC
gnomAD
rs1324265398
CA409270405
173 P>A No ClinGen
gnomAD
CA409270403
rs1324265398
173 P>S No ClinGen
gnomAD
CA9891778
rs766808581
174 L>Q No ClinGen
ExAC
TOPMed
rs775789307
CA409270337
176 Q>* No ClinGen
ExAC
TOPMed
gnomAD
rs775789307
CA9891774
176 Q>E No ClinGen
ExAC
TOPMed
gnomAD
CA409270280
rs1433980467
178 N>K No ClinGen
gnomAD
rs1364941339
CA409270288
178 N>T No ClinGen
gnomAD
CA9891773
rs767911110
179 I>M No ClinGen
ExAC
gnomAD
CA409270270
rs1190202591
179 I>T No ClinGen
gnomAD
CA409270274
rs1390733822
179 I>V No ClinGen
gnomAD
rs200921554
CA409270212
182 I>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1568971920
CA409270198
182 I>T No ClinGen
Ensembl
rs1374260361
CA409270140
184 F>V No ClinGen
gnomAD
rs1210299205
CA409270103
186 L>M No ClinGen
gnomAD
rs1165730747
CA409270094
186 L>P No ClinGen
gnomAD
CA409270087
rs1568971909
187 S>G No ClinGen
Ensembl
rs1418768716
CA409270080
187 S>N No ClinGen
TOPMed
CA9891769
rs770461591
188 F>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA409269969
rs1568971896
193 P>R No ClinGen
Ensembl
CA409269977
rs1339198895
193 P>S No ClinGen
TOPMed
gnomAD
CA9891767
rs772745589
194 E>* No ClinGen
ExAC
gnomAD
TCGA novel 199 D>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1413642589
CA409269830
200 L>R No ClinGen
TOPMed
gnomAD
rs769686341
CA9891765
201 Y>C No ClinGen
ExAC
gnomAD
rs888692560
CA315758868
201 Y>H No ClinGen
TOPMed
rs769686341
CA315758862
201 Y>S No ClinGen
ExAC
gnomAD
CA409269624
rs1164020767
210 T>I No ClinGen
gnomAD
CA9891762
rs754749451
213 N>D No ClinGen
ExAC
gnomAD
CA9891761
rs746121007
214 T>P No ClinGen
ExAC
TOPMed
gnomAD
rs1294278409
CA409269513
215 E>D No ClinGen
TOPMed
rs1187242979
CA409269526
215 E>K No ClinGen
gnomAD
rs779224615
CA9891760
216 T>I No ClinGen
ExAC
gnomAD
rs757533564
CA9891759
217 V>G No ClinGen
ExAC
gnomAD
rs753907842
CA9891757
219 E>K No ClinGen
ExAC
gnomAD
rs1380976197
CA409269405
220 A>G No ClinGen
TOPMed
rs756641225
CA9891755
221 F>I No ClinGen
ExAC
gnomAD
rs756641225
CA9891756
221 F>L No ClinGen
ExAC
gnomAD
rs14872
CA315758808
222 L>M No ClinGen
Ensembl
rs1555885593
CA409269348
224 S>N No ClinGen
Ensembl
CA409269294
rs1486437836
226 S>F No ClinGen
Ensembl
TCGA novel 227 T>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA9891753
rs767873120
227 T>I No ClinGen
ExAC
gnomAD
rs759856429
CA9891752
230 K>Q No ClinGen
ExAC
gnomAD
rs1232144811
CA409269243
230 K>T No ClinGen
gnomAD
rs774016278
CA9891751
232 A>T No ClinGen
ExAC
gnomAD
rs766058573
CA9891750
234 P>L No ClinGen
ExAC
gnomAD
CA9891748
rs772654772
235 V>E No ClinGen
ExAC
CA409269176
rs1294296077
236 L>P No ClinGen
TOPMed
rs1013176758
CA315758774
240 D>A No ClinGen
TOPMed
gnomAD
CA9891745
rs776588426
243 R>H No ClinGen
ExAC
TOPMed
gnomAD
rs1211399912
CA409269006
250 S>P No ClinGen
TOPMed
CA409268988
rs1259347733
251 M>T No ClinGen
TOPMed
rs768590736
CA9891744
251 M>V No ClinGen
ExAC
gnomAD
rs964483765
CA315758744
252 V>A No ClinGen
Ensembl
CA9891743
rs746853072
254 G>Q No ClinGen
ExAC
TOPMed
gnomAD

1 associated diseases with Q96S44

[MIM: 617730]: Galloway-Mowat syndrome 4 (GAMOS4)

A form of Galloway-Mowat syndrome, a severe renal-neurological disease characterized by early-onset nephrotic syndrome associated with microcephaly, central nervous system abnormalities, developmental delays, and a propensity for seizures. Brain anomalies include gyration defects ranging from lissencephaly to pachygyria and polymicrogyria, and cerebellar hypoplasia. Most patients show facial dysmorphism characterized by a small, narrow forehead, large/floppy ears, deep-set eyes, hypertelorism and micrognathia. Additional variable features are visual impairment and arachnodactyly. Most patients die in early childhood. {ECO:0000269|PubMed:28805828}. Note=The disease is caused by variants affecting the gene represented in this entry.

Without disease ID
  • A form of Galloway-Mowat syndrome, a severe renal-neurological disease characterized by early-onset nephrotic syndrome associated with microcephaly, central nervous system abnormalities, developmental delays, and a propensity for seizures. Brain anomalies include gyration defects ranging from lissencephaly to pachygyria and polymicrogyria, and cerebellar hypoplasia. Most patients show facial dysmorphism characterized by a small, narrow forehead, large/floppy ears, deep-set eyes, hypertelorism and micrognathia. Additional variable features are visual impairment and arachnodactyly. Most patients die in early childhood. {ECO:0000269|PubMed:28805828}. Note=The disease is caused by variants affecting the gene represented in this entry.

2 regional properties for Q96S44

Type Name Position InterPro Accession
domain Protein kinase domain 33 - 253 IPR000719
active_site Tyrosine-protein kinase, active site 158 - 170 IPR008266

Functions

Description
EC Number 2.7.11.1 Protein-serine/threonine kinases
Subcellular Localization
  • Cytoplasm
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
EKC/KEOPS complex A protein complex involved in t6A tRNA modification. For example, in Saccharomyces cerevisiae the complex contains Bud32p, Kae1p, Gon7p, Cgi121p, and Pcc1p.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

5 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
hydrolase activity Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc.
p53 binding Binding to one of the p53 family of proteins.
protein serine kinase activity Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate.
protein serine/threonine kinase activity Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.

4 GO annotations of biological process

Name Definition
protein phosphorylation The process of introducing a phosphate group on to a protein.
regulation of signal transduction by p53 class mediator Any process that modulates the frequency, rate or extent of signal transduction by p53 class mediator.
tRNA processing The process in which a pre-tRNA molecule is converted to a mature tRNA, ready for addition of an aminoacyl group.
tRNA threonylcarbamoyladenosine metabolic process The chemical reactions and pathways involving tRNA threonylcarbamoyladenosine, a modified nucleoside found in some tRNA molecules.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MAAARATTPA DGEEPAPEAE ALAAARERSS RFLSGLELVK QGAEARVFRG RFQGRAAVIK
70 80 90 100 110 120
HRFPKGYRHP ALEARLGRRR TVQEARALLR CRRAGISAPV VFFVDYASNC LYMEEIEGSV
130 140 150 160 170 180
TVRDYIQSTM ETEKTPQGLS NLAKTIGQVL ARMHDEDLIH GDLTTSNMLL KPPLEQLNIV
190 200 210 220 230 240
LIDFGLSFIS ALPEDKGVDL YVLEKAFLST HPNTETVFEA FLKSYSTSSK KARPVLKKLD
250
EVRLRGRKRS MVG